Strengthening Pathways for Cell and Gene Therapies

78 Pages

This report evaluates the current state and future outlook of cell and gene therapies (CGTs). While investment, clinical research, and approvals have grown significantly, access remains limited by manufacturing complexity, infrastructure needs, reimbursement challenges, and patient logistics. The report outlines eight indicators to track CGT evolution through 2035, emphasizing the need for coordinated action across regulation, delivery, and payment models to ensure sustainable patient access.

Join for free to read

Strengthening Pathways for Cell and Gene Therapies

Strengthening Pathways for Cell and Gene Therapies

You Might Also Like

More from IQVIA

Report

Strengthening Pathways for Cell and Gene Therapies

Strengthening Pathways for Cell and Gene Therapies

You Might Also Like

More from IQVIA